{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:17:25Z","timestamp":1790320645263,"version":"4.1.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02872","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T04:27:16Z","timestamp":1544156836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"St\u00e9phane","family":"Cauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.cmi.2016.05.029","article-title":"Live pertussis vaccines: will they protect against carriage and spread of pertussis?","volume":"22","author":"Locht","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet Lond Engl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0031-3955(05)70209-1","article-title":"Acellular pertussis vaccines","volume":"47","author":"Decker","year":"2000","journal-title":"Pediatr Clin North Am."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"B5","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines","volume":"65","author":"Ausiello","year":"1997","journal-title":"Infect Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.vaccine.2006.06.046","article-title":"Modulation of the infant immune responses by the first pertussis vaccine administrations","volume":"25","author":"Mascart","year":"2007","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000647","article-title":"Estimating the duration of pertussis immunity using epidemiological signatures","author":"Wearing","year":"2009","journal-title":"PLoS Pathog."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses","volume":"170","author":"Mascart","year":"2003","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e83449","DOI":"10.1371\/journal.pone.0083449","article-title":"A phase I clinical study of a live attenuated Bordetella pertussis vaccine\u2013BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","volume":"9","author":"Thorstensson","year":"2014","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1016\/j.vaccine.2008.08.018","article-title":"Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1","volume":"26","author":"Feunou","year":"2008","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e10178","DOI":"10.1371\/journal.pone.0010178","article-title":"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis","volume":"5","author":"Feunou","year":"2010","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1","volume":"28","author":"Feunou","year":"2010","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/CVI.00371-10","article-title":"A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model","volume":"18","author":"Skerry","year":"2011","journal-title":"Clin Vaccine Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live attenuated pertussis vaccine BPZE1 protects baboons against B. pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1016\/j.vaccine.2016.06.020","article-title":"Heterologous vaccine effects","volume":"34","author":"Saadatian-Elahi","year":"2016","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2017.1333906","article-title":"BCG and protection against inflammatory and auto-immune diseases","volume":"16","author":"Kowalewicz-Kulbat","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fpubh.2018.00079","article-title":"Evidence of increase in mortality after the introduction of diphtheria-tetanus-pertussis vaccine to children aged 6\u201335 months in Guinea-Bissau: a time for reflection?","volume":"6","author":"Aaby","year":"2018","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1016\/j.vaccine.2012.07.005","article-title":"Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice","volume":"30","author":"Kammoun","year":"2012","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1128\/JVI.02542-09","article-title":"Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm","volume":"84","author":"Li","year":"2010","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri3777","article-title":"Epigenetic control of myeloid cell differentiation, identity and function","volume":"15","author":"\u00c1lvarez-Errico","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1164\/rccm.201307-1227OC","article-title":"Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism","volume":"189","author":"Schnoeller","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002173","article-title":"Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus","author":"Sun","year":"2011","journal-title":"PLoS Pathog."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032371","article-title":"IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice","author":"Loebbermann","year":"2012","journal-title":"PLoS ONE"},{"key":"B26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/mi.2011.62","article-title":"Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection","volume":"5","author":"Loebbermann","year":"2012","journal-title":"Mucosal Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1365-2222.2010.03459.x","article-title":"Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model","volume":"40","author":"Kavanagh","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/thx.2005.056291","article-title":"Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma","volume":"61","author":"Harju","year":"2006","journal-title":"Thorax"},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mehy.2018.08.006","article-title":"The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization","volume":"120","author":"Rubin","year":"2018","journal-title":"Med Hypotheses"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.4049\/jimmunol.166.4.2760","article-title":"IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation","volume":"166","author":"Cohn","year":"2001","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1398-9995.2012.02884.x","article-title":"Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models","volume":"67","author":"Li","year":"2012","journal-title":"Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/14760584.2014.882775","article-title":"The Yin-Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation","volume":"13","author":"Tang","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1016\/j.vaccine.2014.07.052","article-title":"A role for impaired regulatory T cell function in adverse responses to aluminum adjuvant-containing vaccines in genetically susceptible individuals","volume":"32","author":"Terhune","year":"2014","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1189\/jlb.1213633","article-title":"Th17 cells and tregs: unlikely allies","volume":"95","author":"Chen","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.055","article-title":"Will we have new pertussis vaccines?","author":"Locht","year":"2017","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.4049\/jimmunol.1003765","article-title":"Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1\/Th17 response","volume":"186","author":"Fedele","year":"2011","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1189\/jlb.3A0315-101R","article-title":"Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine","volume":"98","author":"Fedele","year":"2015","journal-title":"J Leukoc Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","article-title":"Extracellular adenosine-mediated modulation of regulatory T cells","volume":"5","author":"Ohta","year":"2014","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/187152309789151986","article-title":"Pathogenic bacterial proteins and their anti-inflammatory effects in the eukaryotic host","volume":"8","author":"Sun","year":"2009","journal-title":"Anti-Inflamm Anti-Allergy Agents Med Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1128\/IAI.00808-12","article-title":"Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection","volume":"80","author":"Connelly","year":"2012","journal-title":"Infect Immun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00005-013-0242-1","article-title":"The virulence factors of Bordetella pertussis: talented modulators of host immune response","volume":"61","author":"Fedele","year":"2013","journal-title":"Arch Immunol Ther Exp."},{"key":"B44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrmicro3235","article-title":"Bordetella pertussis pathogenesis: current and future challenges","volume":"12","author":"Melvin","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/QCO.0000000000000264","article-title":"Bordetella pertussis: new concepts in pathogenesis and treatment","volume":"29","author":"Carbonetti","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3201\/eid2202.151332","article-title":"Bordetella pertussis strain lacking pertactin and pertussis toxin","volume":"22","author":"Williams","year":"2016","journal-title":"Emerg Infect Dis."},{"key":"B48","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/IAI.62.7.2893-2900.1994","article-title":"Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins","volume":"62","author":"Khelef","year":"1994","journal-title":"Infect Immun."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv073","article-title":"Contribution of pertussis toxin to the pathogenesis of pertussis disease","author":"Carbonetti","year":"2015","journal-title":"Pathog Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-009-9196-9","article-title":"Coughing precipitated by Bordetella pertussis infection","author":"Hewitt","year":"2010","journal-title":"Lung"},{"key":"B51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1099\/00222615-40-3-205","article-title":"Cough production, leucocytosis and serology of rats infected intrabronchially with Bordetella pertussis.","volume":"40","author":"Hall","year":"1994","journal-title":"J Med Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1099\/00222615-40-5-307","article-title":"Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis","volume":"40","author":"Parton","year":"1994","journal-title":"J Med Microbiol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007079","article-title":"Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice","author":"Andreasen","year":"2009","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/toxins3070884","article-title":"Gi\/o protein-dependent and -independent actions of pertussis toxin (PTX)","volume":"3","author":"Mangmool","year":"2011","journal-title":"Toxins"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1128\/IAI.68.3.1735-1739.2000","article-title":"Bordetella pertussis virulence factors affect phagocytosis by human neutrophils","volume":"68","author":"Weingart","year":"2000","journal-title":"Infect Immun."},{"key":"B56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/IAI.55.1.135-140.1987","article-title":"Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions","volume":"55","author":"Friedman","year":"1987","journal-title":"Infect Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.4049\/jimmunol.181.8.5587","article-title":"Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling","volume":"181","author":"Kamanova","year":"2008","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1128\/IAI.00148-12","article-title":"Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation","volume":"80","author":"Henderson","year":"2012","journal-title":"Infect Immun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1128\/IAI.02487-14","article-title":"Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin","volume":"82","author":"Eby","year":"2014","journal-title":"Infect Immun."},{"key":"B60","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1128\/IAI.67.3.1493-1500.1999","article-title":"Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity","volume":"67","author":"Harvill","year":"1999","journal-title":"Infect Immun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mib.2005.12.011","article-title":"Bordetella adenylate cyclase toxin: a swift saboteur of host defense","volume":"9","author":"Vojtova","year":"2006","journal-title":"Curr Opin Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1189\/jlb.72.5.962","article-title":"Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway","volume":"72","author":"Bagley","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4049\/jimmunol.175.2.730","article-title":"Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death","volume":"175","author":"Boyd","year":"2005","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1189\/jlb.0208113","article-title":"Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells","volume":"84","author":"Hickey","year":"2008","journal-title":"J Leukoc Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1128\/iai.72.3.1568-1579.2004","article-title":"Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells","volume":"72","author":"Ross","year":"2004","journal-title":"Infect Immun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e00445","DOI":"10.1128\/IAI.00445-17","article-title":"Bordetella pertussis adenylate cyclase toxin disrupts functional integrity of bronchial epithelial layers","volume":"86","author":"Hasan","year":"2018","journal-title":"Infect Immun."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104064","article-title":"Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells","author":"Adkins","year":"2014","journal-title":"PLoS ONE"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/IAI.73.5.2698-2703.2005","article-title":"Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract","volume":"73","author":"Carbonetti","year":"2005","journal-title":"Infect Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2958.2004.04418.x","article-title":"Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET","volume":"55","author":"Veal-Carr","year":"2005","journal-title":"Mol Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/mmi.13551","article-title":"Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro","volume":"103","author":"Hoffman","year":"2017","journal-title":"Mol Microbiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20011288","article-title":"Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis.","volume":"195","author":"McGuirk","year":"2002","journal-title":"J Exp Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijmm.2015.11.003","article-title":"Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells","volume":"306","author":"Villarino","year":"2016","journal-title":"Int J Med Microbiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/gut.2006.099861","article-title":"Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule","volume":"56","author":"Braat","year":"2007","journal-title":"Gut"},{"key":"B74","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.0507910102","article-title":"Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity","volume":"102","author":"Inatsuka","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41426-018-0039-8","article-title":"Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor","volume":"7","author":"Hovingh","year":"2018","journal-title":"Emerg Microbes Infect."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/S0140-6736(13)62424-1","article-title":"Improving access to vaccines through tiered pricing","volume":"383","author":"Berkley","year":"2014","journal-title":"Lancet Lond Engl."},{"key":"B77","doi-asserted-by":"publisher","first-page":"12282","DOI":"10.1073\/pnas.1413559111","article-title":"Vaccines: science, health, longevity, and wealth","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B78","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/bmj.307.6915.1308","article-title":"Reduced childhood mortality after standard measles vaccination at 4\u20138 months compared with 9-11 months of age","volume":"307","author":"Aaby","year":"1993","journal-title":"BMJ"},{"key":"B79","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrmicro908","article-title":"Can innate immunity be enhanced to treat microbial infections?","volume":"2","author":"Finlay","year":"2004","journal-title":"Nat Rev Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","article-title":"Anti-immunology: evasion of the host immune system by bacterial and viral pathogens","volume":"124","author":"Finlay","year":"2006","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T01:37:51Z","timestamp":1605577071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2018.02872"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02872","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"article-number":"2872"}}